Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Novartis
Novartis
Better Buy: Ariad Pharmaceuticals or Corcept Therapeutics?
Motley Fool
Mon, 09/27/10 - 05:40 pm
Ariad Pharmaceuticals
Corcept Therapeutics
ridaforolimus
Merck
Cushing's disease
Corlux
Novartis
From Cicada Fungus To MS Drug: How Big Will Novartis’ New Pill Be?
Forbes
Mon, 09/27/10 - 11:59 am
Novartis
MS
multiple sclerosis
Gilenya
A Busy Week for Multiple Sclerosis News
Seeking Alpha
Sun, 09/26/10 - 12:24 pm
Novartis
Merck KGaA
Gilenya
multiple sclerosis
cladribine
Biogen Idec
Bayer
Teva Pharmaceuticals
Novartis International AG: Novartis receives EU approval recommendation for TOBI® Podhaler®, a fast and simple therapy that helps reduce treatment burden for cystic fibrosis patients
Fri, 09/24/10 - 12:19 pm
Novartis
TOBI Podhaler
cystic fibrosis
Novartis Hid Health Risks of Bone Drugs, Lawyer Tells Jury in New Jersey
Bloomberg
Fri, 09/24/10 - 11:44 am
Novartis
Zometa
Aredia
Novartis deal over, Alnylam cuts staff
Bizjournals.com
Fri, 09/24/10 - 11:16 am
Novartis
Alnylam
layoffs
RNAi
Novartis to Sell U.S. Rights to Enablex
TheStreet.com
Fri, 09/24/10 - 09:58 am
Novartis
Enablex
Warner Chilcott
overactive bladder
Gilenya: A Blockbuster in Due Time
Motley Fool
Fri, 09/24/10 - 09:55 am
Gilenya
MS
multiple sclerosis
Novartis
Novartis Cushing's Drug Passes Late-Stage Test
TheStreet.com
Wed, 09/22/10 - 09:58 am
Novartis
Cushing's disease
Novartis gains FDA approval for Gilenya drug
Marketwatch
Wed, 09/22/10 - 09:53 am
FDA
Gilenia
Novartis
Gilenya
MS
multiple sclerosis
Novartis Aims for China Trial of Novel Cancer Drug in 2013
Seeking Alpha
Tue, 09/21/10 - 11:14 am
Novartis
China
cancer
Novartis' Multiple Sclerosis Drug Gilenia Poised for Approval
Minyanville
Tue, 09/21/10 - 09:19 am
Novartis
Gilenia
FDA
MS
multiple sclerosis
The Next Big Rare Disease Drug?
Forbes
Wed, 09/15/10 - 09:46 pm
Incyte
Novartis
Janus kinase
AstraZeneca
Eli Lilly
Sanofi
Savient Investors Expect a Sale
TheStreet.com
Wed, 09/15/10 - 08:06 am
Savient
M&A
gout
FDA
Krystexxa
JNJ
Pfizer
Amgen
Novartis
Bristol-Myers Squibb
Did Dendreon Open Doors For Opexa Partnerships?
Yahoo/IndieResearch
Mon, 09/13/10 - 04:02 pm
Opexa
Dendreon
stem cells
Novartis
Novartis's Experimental Meningitis Vaccine Meets Goals in Late-Stage Study
Bloomberg
Mon, 09/13/10 - 12:54 pm
meningitis
vaccines
Novartis
Alnylam Evenly Poised
Yahoo/Zacks.com
Fri, 09/10/10 - 08:15 am
Alnylam
Novartis
Biogen Idec
Roche
Isis Pharmaceuticals
Cubist Pharmaceuticals
Takeda
earnings
Migraine Medication Developers Feeling No Pain
Minyanville
Thu, 09/9/10 - 05:50 pm
migraines
MAP Pharmaceuticals
Novartis
Valeant Pharmaceuticals
Biovail
Allergan
Botox
Migranal
Levadex
Zogenix
Biggest Battles in Biopharma
Fierce Pharma
Wed, 09/8/10 - 11:33 am
Sun Pharma
Taro
Pfizer
Warner-Lambert
Aventis
Sanofi-Synthelabo
Astellas
OSI Pharmaceuticals
King
Alpharma
Novartis
Carl Icahn
Bristol-Myers Squibb
Alcon
Genzyme
Teva Wins Copaxone Protection
Forbes
Tue, 09/7/10 - 05:03 pm
Teva Pharmaceuticals
Copaxone
MS
multiple sclerosis
patents
Novartis
Momenta
Pages
« first
‹ previous
…
143
144
145
146
147
148
149
150
151
…
next ›
last »